Omolola Adeoye-Olatunde

Dr. Omolola Adeoye-Olatunde

Purdue University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
Omolola Adeoye-OlatundeOmolola Adeoye-Olatunde
Omolola Adeoye-Olatunde
NONicole L. Olenik
Nicole L. Olenik


1 July 2018 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
Omolola Adeoye-OlatundeOmolola Adeoye-Olatunde
Omolola Adeoye-Olatunde
LLLeslie M. Lake
Leslie M. Lake
SLSpencer G. Lourens
Spencer G. Lourens
RMRachel E. Morris
Rachel E. Morris
MSMargie E. Snyder
Margie E. Snyder

1 May 2020 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
DPDeborah L. Pestka
Deborah L. Pestka
AZAlan J. Zillich
Alan J. Zillich
ACAntoinette B. Coe
Antoinette B. Coe
KFKaren B. Farris
Karen B. Farris
Omolola Adeoye-OlatundeOmolola Adeoye-Olatunde
Omolola Adeoye-Olatunde
JFJoel F. Farley
Joel F. Farley

1 September 2020 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
ACAntoinette B. Coe
Antoinette B. Coe
Omolola Adeoye-OlatundeOmolola Adeoye-Olatunde
Omolola Adeoye-Olatunde
DPDeborah L. Pestka
Deborah L. Pestka
MSMargie E. Snyder
Margie E. Snyder
AZAlan J. Zillich
Alan J. Zillich
JFJoel F. Farley
Joel F. Farley

29 June 2019 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
Omolola Adeoye-OlatundeOmolola Adeoye-Olatunde
Omolola Adeoye-Olatunde
JFJoel F. Farley
Joel F. Farley
ACAntoinette B. Coe
Antoinette B. Coe
DPDeborah L. Pestka
Deborah L. Pestka
KFKaren B Farris
Karen B Farris
MSMargie E. Snyder
Margie E. Snyder
Introduction: The Medicare Part D medication therapy management (MTM) program positions pharmacists to optimize beneficiaries' medications and improve care. Little is known regarding Part D MTM delivery by community pharmacists and other pharmacist provider types. Objectives: To (a) characterize Medicare Part D MTM delivery by community pharmacists, (b) compare MTM delivery by community pharmacists to other pharmacists, and (c) generate hypotheses for future research. Methods: A descriptive cross‐sectional study using merged data from a 20% random sample of Medicare beneficiary enrollment data with a 100% sample of recently available 2014 Part D MTM files was conducted. Andersen's Behavioral Model was applied to describe MTM delivery across beneficiary characteristics. Descriptive and bivariate statistics were used to compare delivery of MTM between community and other pharmacist providers. Results: Among beneficiaries sampled, community pharmacists provided comprehensive medication reviews (CMRs) to 22% (n = 26 337) of beneficiaries receiving at least one CMR. Almost half (49.4%) were provided face‐to‐face. Across pharmacist cohorts, median days to CMR offer of post‐MTM program enrollment were within the 60‐day policy requirement. The community pharmacist cohort had fewer days from CMR offer to receipt (median 47 days). Community pharmacists provided more medication therapy problem (MTP) recommendations (mean [SD] of 1.8 [3.5]; P < .001), but resolved less MTPs (0.2 [0.7]; P < .001), and most commonly served beneficiaries that were in the south but less in the west/northeast. Additionally, community pharmacists served a smaller proportion of black beneficiaries, yet a larger proportion of Hispanic beneficiaries ( P < .001). Conclusion: Community pharmacists provided approximately one in five CMRs for MTM eligible beneficiaries in 2014, with CMRs occurring more quickly, resulting in more MTP recommendations, but resolving less MTPs than those provided by noncommunity pharmacists. Future research should explore geographic/racial‐ethnic disparities in beneficiaries served and strategies to increase negligible MTP resolution by community pharmacists.